The Liver Unit, Queen Elizabeth University Hospital, Birmingham, United Kingdom; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
The Liver Unit, Queen Elizabeth University Hospital, Birmingham, United Kingdom.
HPB (Oxford). 2019 Dec;21(12):1707-1717. doi: 10.1016/j.hpb.2019.04.008. Epub 2019 May 29.
Acute kidney injury (AKI) is a frequent complication after liver transplantation. Although numerous risk factors for AKI have been identified, their cumulative impact remains unclear. Our aim was therefore to design a new model to predict post-transplant AKI.
Risk analysis was performed in patients undergoing liver transplantation in two centres (n = 1230). A model to predict severe AKI was calculated, based on weight of donor and recipient risk factors in a multivariable regression analysis according to the Framingham risk-scheme.
Overall, 34% developed severe AKI, including 18% requiring postoperative renal replacement therapy (RRT). Five factors were identified as strongest predictors: donor and recipient BMI, DCD grafts, FFP requirements, and recipient warm ischemia time, leading to a range of 0-25 score points with an AUC of 0.70. Three risk classes were identified: low, intermediate and high-risk. Severe AKI was less frequently observed if recipients with an intermediate or high-risk were treated with a renal-sparing immunosuppression regimen (29 vs. 45%; p = 0.007).
The AKI Prediction Score is a new instrument to identify recipients at risk for severe post-transplant AKI. This score is readily available at end of the transplant procedure, as a tool to timely decide on the use of kidney-sparing immunosuppression and early RRT.
急性肾损伤(AKI)是肝移植后的常见并发症。尽管已经确定了许多 AKI 的风险因素,但它们的累积影响仍不清楚。因此,我们的目的是设计一种新的模型来预测移植后 AKI。
在两个中心(n=1230)进行肝移植的患者中进行风险分析。根据 Framingham 风险方案,在多变量回归分析中,根据供体和受者的风险因素计算出预测严重 AKI 的模型。
总体而言,34%的患者发生严重 AKI,包括 18%需要术后肾脏替代治疗(RRT)。有五个因素被确定为最强的预测因素:供体和受者的 BMI、DCD 移植物、FFP 需求以及受者的热缺血时间,导致分数范围为 0-25 分,AUC 为 0.70。确定了三个风险类别:低危、中危和高危。如果中危或高危患者接受肾脏保护免疫抑制方案治疗,严重 AKI 的发生率较低(29%比 45%;p=0.007)。
AKI 预测评分是一种新的工具,可以识别移植后发生严重 AKI 的高危患者。该评分在移植结束时即可获得,可作为及时决定使用肾脏保护免疫抑制和早期 RRT 的工具。